Država: Irska
Jezik: angleščina
Source: HPRA (Health Products Regulatory Authority)
MIRTAZAPINE
Medis ehf
MIRTAZAPINE
45 Milligram
Film Coated Tablet
Product subject to prescription which may not be renewed (A)
Withdrawn
0000-00-00
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Mirtazapine Medis 45 mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each Film-Coated tablet contains 45 mg of mirtazapine. Excipients: Each film-coated tablet contains 305.4 mg lactose (as monohydrate). For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet White, oval biconvex. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of episodes of major depression. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Adults_ The effective daily dose is usually between 15 and 45 mg; the starting dose is 15 or 30 mg. Mirtazapine begins to exert its effect in general after 1-2 weeks of treatment. Treatment with an adequate dose should result in a positive response within 2-4 weeks. With an insufficient response, the dose can be increased up to the maximum dose. If there is no response within a further 2-4 weeks, then treatment should be stopped. _Elderly_ The recommended dose is the same as that for adults. In elderly patients an increase in dosing should be done under close supervision to elicit a satisfactory and safe response. _Children and adolescents under the age of 18 years_ Mirtazapine should not be used in children and adolescents under the age of 18 years (see section 4.4) as efficacy was not demonstrated in two short-term clinical trials (see section 5.1) and because of safety concerns (see sections 4.4, 4.8 and 5.1). _Renal Impairment_ The clearance of mirtazapine may be decreased in patients withmoderate to sever renal impairment (creatinine clearance < 40 ml/min). This should be taken into account when prescribing mirtazapine to this category of patients (see section 4.4). _Hepatic Impairment_ The clearance of mirtazapine may be decreased in pa Preberite celoten dokument